Difference between revisions of "Category:Antibody medications"
Jump to navigation
Jump to search
m |
m |
||
| Line 1: | Line 1: | ||
A class of agents that are for the most part engineered monoclonal antibodies. Includes drug conjugates, which are typically denoted by a second name, e.g. [[Brentuximab vedotin (Adcetris)|brentuximab ''vedotin'']]. Note that some monoclonal antibodies operate through immunotherapeutic mechanisms, whereas others are directly cytotoxic (and some are both). | A class of agents that are for the most part engineered monoclonal antibodies. Includes drug conjugates, which are typically denoted by a second name, e.g. [[Brentuximab vedotin (Adcetris)|brentuximab ''vedotin'']]. Note that some monoclonal antibodies operate through immunotherapeutic mechanisms, whereas others are directly cytotoxic (and some are both). | ||
| − | [[Category: | + | [[Category:Drug index]] |
| − | |||
Revision as of 20:48, 5 August 2017
A class of agents that are for the most part engineered monoclonal antibodies. Includes drug conjugates, which are typically denoted by a second name, e.g. brentuximab vedotin. Note that some monoclonal antibodies operate through immunotherapeutic mechanisms, whereas others are directly cytotoxic (and some are both).
Subcategories
This category has the following 6 subcategories, out of 6 total.